Checkpoint therapy in cancer treatment: progress, challenges, and future directions
Journal of Clinical Investigation · 17.09.2024 · 134 (18)
DOI: 10.1172/jci184846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.09.2024. Verfasst von Mesude Bicak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Cell Therapy Laboratory and. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vaccine and Cell Therapy Laboratory and.
- Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
Zitieren
APA
Bicak, M., Cimen Bozkus, C., & Bhardwaj, N. (2024). Checkpoint therapy in cancer treatment: progress, challenges, and future directions. Journal of Clinical Investigation, 134(18). https://doi.org/10.1172/jci184846
Vancouver
Bicak M, Cimen Bozkus C, Bhardwaj N. Checkpoint therapy in cancer treatment: progress, challenges, and future directions. Journal of Clinical Investigation. 2024;134(18). doi:10.1172/jci184846
BibTeX
@article{Bicak2024,
author = {Bicak, Mesude and Cimen Bozkus, Cansu and Bhardwaj, Nina},
title = {Checkpoint therapy in cancer treatment: progress, challenges, and future directions},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {18},
doi = {10.1172/jci184846}
}
EUVIMED